معرفی
Dr. David Conrad is an Associate Professor in the Departments of Pathology, Microbiology & Immunology, and Pediatrics at Dalhousie University. He serves as Division Head of Hematopathology at the IWK Health Centre and Section Head for Molecular Hematopathology in the Molecular Diagnostic Laboratory at Nova Scotia Health Authority. His roles include leadership in diagnostic hematology and molecular pathology. Dr. Conrad completed his MD and PhD at Dalhousie University (2011 and 2007, respectively), following a BSc in 2002. He is also Vice Chair of the Hematological Pathology Examination Committee for the Royal College of Physicians and Surgeons of Canada.
Education:
- BSc, Dalhousie University, 2002
- PhD, Dalhousie University, 2007
- MD, Dalhousie University, 2011
- FRCPC in Hematological Pathology, Dalhousie University, 2015
Research Focus: Dr. Conrad’s work centers on optimizing diagnostic tools in hematology laboratories to improve patient care efficiency. His research spans hematopathology, molecular diagnostics, and pediatric hematology. Recent projects include developing proficiency assessment programs for blood morphology and creating patient-centered educational initiatives like the CELLFIE Project for pediatric leukemia patients.
Publications Trends: Recent articles highlight advancements in diagnostic algorithms (e.g., automated blast detection), molecular pathology (e.g., hepcidin’s role in myeloma), and educational tools for clinicians and patients. His work often bridges clinical practice and technology innovation, emphasizing cost-effective solutions.
Awards: None explicitly listed.
Advising & Grants: Currently unavailable to supervise new trainees. No specific grants highlighted in the provided text.
Labs/Teams: Leads the Hematopathology Division at IWK Health Centre and directs molecular diagnostics efforts in Nova Scotia Health Authority’s Central Zone.